Synthesis and biological evaluation of N-arylated-lactam-type iminosugars as potential immunosuppressive agents.

Since the immunosuppressive agents currently used in clinics have significant side effects, it is very important to search for new effective and safe immunosuppressants. Iminosugars as a new class of immunosuppressants are less explored. In this report, 24 new N-arylated iminosugar derivatives, including d-talo and d-galacto epimers, were designed and synthesized, and their immunosuppressive effects were evaluated by MTT assay. The experimental data demonstrated that compound 20 showed the strongest inhibition effect (IC50 = 6.94 μM). Further studies revealed that the inhibitory effects on splenocyte proliferation may come from the suppression of both IFN-γ and IL-4 cytokines. The preliminary structure-activity relationship (SAR) analysis suggested that N-arylated d-galacto-type iminosugars showed better inhibitory activities than d-talo-type analogues. The SAR analysis also showed that the inhibition effect of iminosugars can be improved by decreasing the polarity or increasing the hydrophobicity. These results may be beneficial to the discovery of new iminosugar derivatives as immunosuppressive agents.

[1]  G. Tai,et al.  Synthesis of N-dialkylphosphoryl iminosugar derivatives and their immunosuppressive activities. , 2015, Organic & biomolecular chemistry.

[2]  Qin Li,et al.  Iminosugars as Immunomodulating Agents: Synthesis and Biological Activities of 1‐Deoxynojirimycin and Related Compounds , 2015 .

[3]  Xin‐Shan Ye,et al.  Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway. , 2014, International immunopharmacology.

[4]  Anamik Shah,et al.  Subtle Mitsunobu couplings under super-heating: the role of high-throughput continuous flow and microwave strategies. , 2014, Organic & biomolecular chemistry.

[5]  Yifa Zhou,et al.  N-arylated-lactam-type iminosugars as new immunosuppressive agents: discovery, optimization, and biological evaluation. , 2014, Chemistry, an Asian journal.

[6]  Xiao-lian Zhang,et al.  An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases. , 2012, Bioorganic & medicinal chemistry letters.

[7]  Li-he Zhang,et al.  Design and syntheses of some iminosugar derivatives as potential immunosuppressants , 2011 .

[8]  Mark S. Taylor,et al.  Regioselective activation of glycosyl acceptors by a diarylborinic acid-derived catalyst. , 2011, Journal of the American Chemical Society.

[9]  Li-he Zhang,et al.  Synthetic N-alkylated iminosugars as new potential immunosuppressive agents. , 2011, ACS medicinal chemistry letters.

[10]  Lina Chan,et al.  Regioselective alkylation of carbohydrate derivatives catalyzed by a diarylborinic acid derivative. , 2011, Organic letters.

[11]  Janice M. H. Cheng,et al.  An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cells. , 2011, Carbohydrate research.

[12]  Mark S. Taylor,et al.  Borinic acid-catalyzed regioselective acylation of carbohydrate derivatives. , 2011, Journal of the American Chemical Society.

[13]  Li-he Zhang,et al.  Synthesis of N-substituted iminosugar derivatives and their immunosuppressive activities. , 2010, Carbohydrate research.

[14]  Mark S. Taylor,et al.  Boron-catalyzed direct aldol reactions of pyruvic acids. , 2009, Organic letters.

[15]  Yongming Zhang,et al.  An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-gamma and IL-4. , 2008, Bioorganic & medicinal chemistry.

[16]  V. Puranik,et al.  Synthesis of 1-deoxy-1-hydroxymethyl- and 1-deoxy-1-epi-hydroxymethyl castanospermine as new potential immunomodulating agents. , 2007, Journal of medicinal chemistry.

[17]  Li-he Zhang,et al.  Synthetic iminosugar derivatives as new potential immunosuppressive agents. , 2005, Journal of medicinal chemistry.

[18]  Xiaoping Zhou,et al.  Specific inhibition effects of N-pentafluorobenzyl-1-deoxynojirimycin on human CD4+ T cells. , 2004, Bioorganic & Medicinal Chemistry Letters.

[19]  K. Whitby,et al.  Action of Celgosivir (6 O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C , 2004, Antiviral chemistry & chemotherapy.

[20]  B. Engelhardt,et al.  Glycosylation processing inhibition by castanospermine prevents experimental autoimmune encephalomyelitis by interference with IL-2 receptor signal transduction , 2002, Journal of Neuroimmunology.

[21]  J Alper,et al.  Searching for Medicine's Sweet Spot , 2001, Science.

[22]  E. Clercq.  Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection , 2000 .

[23]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[24]  M. Reitz,et al.  Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. , 1998, Blood.

[25]  H Nojima,et al.  Antihyperglycemic effects of N-containing sugars from Xanthocercis zambesiaca, Morus bombycis, Aglaonema treubii, and Castanospermum australe in streptozotocin-diabetic mice. , 1998, Journal of natural products.

[26]  W. Cowden,et al.  Castanospermine, an oligosaccharide-processing inhibitor, reduces membrane expression of adhesion molecules and prolongs heart allograft survival in rats. , 1996, Transplantation proceedings.

[27]  J. Dennis,et al.  Inhibitors of carbohydrate processing: A new class of anticancer agents. , 1995, Clinical Cancer Research.

[28]  A. Passaniti,et al.  The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth , 1995 .

[29]  M. Kang,et al.  The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection. , 1995, Glycobiology.

[30]  P. Guillou,et al.  Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity. , 1994, Immunopharmacology.

[31]  D. McTavish,et al.  Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus. , 1993, Drugs.

[32]  S. Koda,et al.  Structure of kifunensine, a new immunomodulator isolated from an actinomycete , 1989 .

[33]  Paul W Smith,et al.  Inhibition of HIV replication by amino‐sugar derivatives , 1988, FEBS letters.

[34]  K. A. Wall,et al.  Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Masaaki Yoshida,et al.  Hydrogenation of 4-substituted biphenyls , 1987 .

[36]  H. Imanaka,et al.  Studies of an immunomodulator, swainsonine. I. Enhancement of immune response by swainsonine in vitro. , 1985, The Journal of antibiotics.

[37]  D. Dess,et al.  Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones , 1983 .

[38]  R. F. Brady.  Cyclic Acetals of Ketoses , 1970 .

[39]  S. Inouye,et al.  The structure of nojirimycin, a piperidinose sugar antibiotic. , 1966, The Journal of antibiotics.